litlas
Log inCreate account

Jeffrey D. Lifson

Active 1986–2025

195
Papers
38,156
Citations
110
h-index
191
i10-index

Citations

Citations per year for Jeffrey D. Lifson1986: 8 citations1987: 36 citations1988: 79 citations1989: 52 citations1990: 72 citations1991: 59 citations1992: 41 citations1993: 44 citations1994: 25 citations1995: 60 citations1996: 156 citations1997: 160 citations1998: 148 citations1999: 133 citations2000: 166 citations2001: 145 citations2002: 141 citations2003: 144 citations2004: 198 citations2005: 236 citations2006: 246 citations2007: 278 citations2008: 263 citations2009: 256 citations2010: 302 citations2011: 345 citations2012: 347 citations2013: 327 citations2014: 266 citations2015: 303 citations2016: 320 citations2017: 280 citations2018: 318 citations2019: 1,107 citations2020: 1,055 citations2021: 954 citations2022: 637 citations2023: 450 citations2024: 662 citations2025: 310 citations2026: 21 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,808 citing papers, 44.6% of this breakdownUnited Kingdom: 800 citing papers, 7.4% of this breakdownFrance: 522 citing papers, 4.8% of this breakdownGermany: 472 citing papers, 4.4% of this breakdownCanada: 455 citing papers, 4.2% of this breakdownChina: 390 citing papers, 3.6% of this breakdownNetherlands: 342 citing papers, 3.2% of this breakdownAustralia: 294 citing papers, 2.7% of this breakdownSwitzerland: 248 citing papers, 2.3% of this breakdownItaly: 248 citing papers, 2.3% of this breakdownSouth Africa: 230 citing papers, 2.1% of this breakdownSpain: 222 citing papers, 2.1% of this breakdown
0%44.6%Other 16.3%

Institutions

Fields

  • Immunology and Microbiology64.8%
  • Medicine21.8%
  • Biochemistry, Genetics and Molecular Biology9.2%
  • Agricultural and Biological Sciences1.4%
  • Neuroscience0.6%
  • Environmental Science0.5%
  • Other1.7%

Topics

  • HIV Research and Treatment20.6%
  • Immune Cell Function and Interaction10.4%
  • HIV/AIDS drug development and treatment6.4%
  • HIV/AIDS Research and Interventions5.5%
  • T-cell and B-cell Immunology5%
  • Immunotherapy and Immune Responses3.4%
  • Other48.7%

Coauthors

All papers

Open in search
  1. Defining total-body AIDS-virus burden with implications for curative strategies

    Authors: Jacob D. Estes, Cissy Kityo, Francis Ssali, Louise Swainson, Krystelle Nganou Makamdop, Gregory Q. Del Prete, Steven G. Deeks, Paul A. Luciw, Jeffrey G. Chipman, Gregory J. Beilman, Torfi Hoskuldsson, Alexander Khoruts, Jodi Anderson, Claire Deléage, Jacob Jasurda, Thomas Schmidt, Michael Hafertepe, Samuel P. Callisto, Hope Pearson, Thomas Reimann, Jared Schuster, Jordan Schoephoerster, Peter J. Southern, Katherine Perkey, Liang Shang, Stephen W. Wietgrefe, Courtney V. Fletcher, Jeffrey D. Lifson, Daniel C. Douek, Joseph M. McCune, Ashley T. Haase, Timothy W. Schacker - Nature Medicine 2017 cited by 416

  2. Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo

    Authors: Christopher C. Nixon, Maud Mavigner, Gavin C. Sampey, Alyssa D. Brooks, Rae Ann Spagnuolo, David M. Irlbeck, Cameron Mattingly, Phong T. Ho, Nils Schoof, Corinne G. Cammon, Greg K. Tharp, Matthew Kanke, Zhang Wang, Rachel A. Cleary, Amit A. Upadhyay, Chandrav De, Saintedym R. Wills, Shane D. Falcinelli, Cristin M. Galardi, Hasse Walum, Nathaniel J. Schramm, Jennifer Deutsch, Jeffrey D. Lifson, Christine M. Fennessey, Brandon F. Keele, Sherrie Jean, Sean Maguire, Baolin Liao, Edward P. Browne, Robert G. Ferris, Jessica H. Brehm, David Favre, Thomas H. Vanderford, Steven E. Bosinger, Corbin D. Jones, Jean‐Pierre Routy, Nancie M. Archin, David M. Margolis, Angela Wahl, Richard M. Dunham, Guido Silvestri, Ann Chahroudi, J. Víctor García - Nature 2020 cited by 319

  3. Early antibody therapy can induce long-lasting immunity to SHIV

    Authors: Yoshiaki Nishimura, Rajeev Gautam, Tae‐Wook Chun, Reza Sadjadpour, Kathryn E. Foulds, Masashi Shingai, Florian Klein, Anna Gazumyan, Jovana Golijanin, Mitzi M. Donaldson, Olivia K. Donau, Ronald J. Plishka, Alicia Buckler‐White, Michael S. Seaman, Jeffrey D. Lifson, Richard A. Koup, Anthony S. Fauci, Michel C. Nussenzweig, Malcolm A. Martin - Nature 2017 cited by 317

  4. Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection

    Authors: Rebecca M. Lynch, Eli Boritz, Emily E. Coates, Adam DeZure, Patrick Madden, Pamela Costner, Mary E. Enama, Sarah H. Plummer, LaSonji A. Holman, Cynthia S. Hendel, Ingelise J. Gordon, Joseph P. Casazza, Michelle Conan-Cibotti, Stephen A. Migueles, Randall Tressler, Robert T. Bailer, Adrian B. McDermott, Sandeep Narpala, Sijy O’Dell, Gideon Wolf, Jeffrey D. Lifson, Brandie A. Freemire, Robert J. Gorelick, Janardan P. Pandey, Sarumathi Mohan, Nicolas Chomont, Rémi Fromentin, Tae‐Wook Chun, Anthony S. Fauci, Richard Schwartz, Richard A. Koup, Daniel C. Douek, Zonghui Hu, Edmund V. Capparelli, Barney S. Graham, John R. Mascola, Julie E. Ledgerwood, VRC 601 Study Team - Science Translational Medicine 2015 cited by 479

  5. Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1

    Authors: Angela Meier, J. Judy Chang, Ellen S. Chan, Richard B. Pollard, Harlyn K. Sidhu, Smita Kulkarni, Tom Fang Wen, Robert Lindsay, Liliana Orellana, Donna Mildvan, Suzane Bazner, Hendrik Streeck, Galit Alter, Jeffrey D. Lifson, Mary Carrington, Ronald J. Bosch, Gregory K. Robbins, Marcus Altfeld - Nature Medicine 2009 cited by 589

  6. Immune clearance of highly pathogenic SIV infection

    Authors: Scott G. Hansen, Michael Piatak, Abigail B. Ventura, Colette M. Hughes, Roxanne M. Gilbride, Julia C. Ford, Kelli Oswald, Rebecca Shoemaker, Yuan Li, Matthew S. Lewis, Awbrey N. Gilliam, Guangwu Xu, Nathan Whizin, Benjamin J. Burwitz, Shannon Planer, John M. Turner, Alfred W. Legasse, Michael K. Axthelm, Jay A. Nelson, Klaus Früh, Jonah B. Sacha, Jacob D. Estes, Brandon F. Keele, Paul T. Edlefsen, Jeffrey D. Lifson, Louis J. Picker - Nature 2013 cited by 622

  7. Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells

    Authors: Julia Bergild McBrien, Maud Mavigner, Lavinia Franchitti, S. Abigail Smith, Erick White, Gregory K. Tharp, Hasse Walum, Kathleen Busman‐Sahay, Christian R. Aguilera-Sandoval, William O. Thayer, Rae Ann Spagnuolo, Martina Kovářová, Angela Wahl, Barbara Cervasi, David M. Margolis, Thomas H. Vanderford, Diane G. Carnathan, Mirko Paiardini, Jeffrey D. Lifson, John H. Lee, Jeffrey T. Safrit, Steven E. Bosinger, Jacob D. Estes, Cynthia A. Derdeyn, J. Víctor García, Deanna A. Kulpa, Ann Chahroudi, Guido Silvestri - Nature 2020 cited by 195

  8. HIV-1 Env trimers asymmetrically engage CD4 receptors in membranes

    Authors: Wenwei Li, Zhuan Qin, Elizabeth Nand, Michael W. Grunst, Jonathan R. Grover, Julian W. Bess, Jeffrey D. Lifson, Michael B. Zwick, Hemant D. Tagare, Pradeep D. Uchil, Walther Mothes - Nature 2023 cited by 63

  9. Envelope residue 375 substitutions in simian–human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques

    Authors: Hui Li, Shuyi Wang, Rui Kong, Wenge Ding, Fang-Hua Lee, Zahra Parker, Eunlim Kim, Gerald H. Learn, Paul Hahn, B. Policicchio, Egidio Brocca‐Cofano, Claire Deléage, Xingpei Hao, Gwo‐Yu Chuang, Jason Gorman, Matthew R. Gardner, Mark G. Lewis, Théodora Hatziioannou, Sampa Santra, Cristian Apetrei, Ivona Pandrea, S. Munir Alam, Hua-Xin Liao, Xiaoying Shen, Georgia D. Tomaras, Michael Farzan, Elena Chertova, Brandon F. Keele, Jacob D. Estes, Jeffrey D. Lifson, Robert W. Doms, David C. Montefiori, Barton F. Haynes, Joseph Sodroski, Peter D. Kwong, Beatrice H. Hahn, George M. Shaw - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 239

  10. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression

    Authors: Netanya G. Sandler, Steven E. Bosinger, Jacob D. Estes, Richard T. Zhu, Gregory K. Tharp, Eli Boritz, Doron Levin, Sathi Wijeyesinghe, Krystelle Nganou Makamdop, Gregory Q. Del Prete, Brenna J. Hill, J. Katherina Timmer, Emma I. M. M. Reiss, Ganit Yarden, Samuel Darko, Eduardo J. Contijoch, John Paul Todd, Guido Silvestri, Martha Nason, Robert B. Norgren, Brandon F. Keele, Srinivas S. Rao, Jerome A. Langer, Jeffrey D. Lifson, Gideon Schreiber, Daniel C. Douek - Nature 2014 cited by 463

  11. Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy

    Authors: Thomas S. Uldrick, Scott V. Adams, Rémi Fromentin, Michael Roche, Steven P. Fling, Priscila Gonçalves, Kathryn Lurain, Ramya Ramaswami, Chia-Ching Jackie Wang, Robert J. Gorelick, Jorden L. Welker, Liz O’Donoghue, Harleen Choudhary, Jeffrey D. Lifson, Thomas A. Rasmussen, Ajantha Rhodes, Carolin Tumpach, Robert Yarchoan, Frank Maldarelli, Martin A. Cheever, Rafick‐Pierre Sékaly, Nicolas Chomont, Steven G. Deeks, Sharon R. Lewin - Science Translational Medicine 2022 cited by 102

  12. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine

    Authors: Scott G. Hansen, Julia C. Ford, Matthew S. Lewis, Abigail B. Ventura, Colette M. Hughes, Lia Coyne-Johnson, Nathan Whizin, Kelli Oswald, Rebecca Shoemaker, Tonya Swanson, Alfred W. Legasse, Marı́a J. Chiuchiolo, Christopher L. Parks, Michael K. Axthelm, Jay A. Nelson, Michael A. Jarvis, Michael Piatak, Jeffrey D. Lifson, Louis J. Picker - Nature 2011 cited by 1,002

  13. Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions

    Authors: Ping Zhu, Elena Chertova, Julian W. Bess, Jeffrey D. Lifson, Larry O. Arthur, Jun Liu, Kenneth A. Taylor, Kenneth H. Roux - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 421

  14. Distribution and three-dimensional structure of AIDS virus envelope spikes

    Authors: Ping Zhu, Jun Liu, Julian W. Bess, Elena Chertova, Jeffrey D. Lifson, Henry Grisé, Gilad Ofek, Kenneth A. Taylor, Kenneth H. Roux - Nature 2006 cited by 768

  15. Defining HIV and SIV Reservoirs in Lymphoid Tissues

    Authors: Claire Deléage, Stephen W. Wietgrefe, Gregory Q. Del Prete, David R. Morcock, Xingpei Hao, Michael Piatak, Julian W. Bess, Jodi Anderson, Katherine Perkey, Cavan Reilly, Joseph M. McCune, Ashley T. Haase, Jeffrey D. Lifson, Timothy W. Schacker, Jacob D. Estes - Pathogens and Immunity 2016 cited by 262

  16. CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption

    Authors: Justin Harper, Shari N. Gordon, Chi Ngai Chan, Hong Wang, Emily Lindemuth, Cristin M. Galardi, Shane D. Falcinelli, Samuel L M Raines, Jenna Read, Kevin Nguyen, Colleen S. McGary, Michael Nekorchuk, Kathleen Busman‐Sahay, James Schawalder, Colin T. King, María Pino, Luca Micci, Barbara Cervasi, Sherrie Jean, Andrew Sanderson, Brian A. Johns, A. Alicia Koblansky, Heather Amrine‐Madsen, Jeffrey D. Lifson, David M. Margolis, Guido Silvestri, Katharine J. Bar, David Favre, Jacob D. Estes, Mirko Paiardini - Nature Medicine 2020 cited by 106

  17. AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges

    Authors: Matthew R. Gardner, Lisa Kattenhorn, Hema R. Kondur, Markus von Schaewen, Tatyana Dorfman, Jessica J. Chiang, Kevin G. Haworth, Julie M. Decker, Michael D. Alpert, Charles C. Bailey, Ernest S. Neale, Christoph H. Fellinger, Vinita R. Joshi, Sebastian Fuchs, José M. Martinez-Navío, Brian D. Quinlan, Annie Y. Yao, Hugo Mouquet, Jason Gorman, Baoshan Zhang, Pascal Poignard, Michel C. Nussenzweig, Dennis R. Burton, Peter D. Kwong, Michael Piatak, Jeffrey D. Lifson, Guangping Gao, Ronald C. Desrosiers, David T. Evans, Beatrice H. Hahn, Alexander Ploß, Paula M. Cannon, Michael S. Seaman, Michael Farzan - Nature 2015 cited by 302

  18. Viral dynamics in human immunodeficiency virus type 1 infection

    Authors: Xiping Wei, Sajal K. Ghosh, Maria E. Taylor, Victoria A. Johnson, Emilio A. Emini, Paul Deutsch, Jeffrey D. Lifson, Sebastian Bonhoeffer, Martin A. Nowak, Beatrice H. Hahn, Michael S Saag, George M. Shaw - Nature 1995 cited by 3,294

  19. B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers

    Authors: Yoshinori Fukazawa, Richard Lum, Afam A. Okoye, Haesun Park, Kenta Matsuda, Jin Young Bae, Shoko I. Hagen, Rebecca Shoemaker, Claire Deléage, Carissa M. Lucero, David R. Morcock, Tonya Swanson, Alfred W. Legasse, Michael K. Axthelm, Joseph Hesselgesser, Romas Geleziunas, Vanessa M. Hirsch, Paul T. Edlefsen, Michael Piatak, Jacob D. Estes, Jeffrey D. Lifson, Louis J. Picker - Nature Medicine 2015 cited by 480

  20. Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia

    Authors: Masashi Shingai, Yoshiaki Nishimura, Florian Klein, Hugo Mouquet, Olivia K. Donau, Ronald J. Plishka, Alicia Buckler‐White, Michael S. Seaman, Michael Piatak, Jeffrey D. Lifson, Dimiter S. Dimitrov, Michel C. Nussenzweig, Malcolm A. Martin - Nature 2013 cited by 457

  21. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge

    Authors: Scott G. Hansen, Cassandra Vieville, Nathan Whizin, Lia Coyne-Johnson, Don Siess, Derek D. Drummond, Alfred W. Legasse, Michael K. Axthelm, Kelli Oswald, Charles M. Trubey, Michael Piatak, Jeffrey D. Lifson, Jay A. Nelson, Michael A. Jarvis, Louis J. Picker - Nature Medicine 2009 cited by 673

  22. A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge

    Authors: Scott G. Hansen, Emily E. Marshall, Daniel Malouli, Abigail B. Ventura, Colette M. Hughes, Emily Ainslie, Julia C. Ford, David Morrow, Roxanne M. Gilbride, Jin Young Bae, Alfred W. Legasse, Kelli Oswald, Rebecca Shoemaker, Brian Berkemeier, William J. Bosche, Michael Hull, Jennie Womack, Jason Shao, Paul T. Edlefsen, Jason S. Reed, Ben J. Burwitz, Jonah B. Sacha, Michael K. Axthelm, Klaus Früh, Jeffrey D. Lifson, Louis J. Picker - Science Translational Medicine 2019 cited by 112

  23. The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections

    Authors: Alexandra M. Bender, Francesco R. Simonetti, Mithra R. Kumar, Emily J. Fray, Katherine M. Bruner, Andrew E. Timmons, Katherine Y. Tai, Katharine M. Jenike, Annukka A.R. Antar, Po-Ting Liu, Ya‐Chi Ho, Dana N. Raugi, Moussa Seydi, Geoffrey S. Gottlieb, Afam A. Okoye, Gregory Q. Del Prete, Louis J. Picker, Joseph L. Mankowski, Jeffrey D. Lifson, Janet D. Siliciano, Greg M. Laird, Dan H. Barouch, Janice E. Clements, Robert F. Siliciano - Cell Host & Microbe 2019 cited by 102

  24. Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune Activation

    Authors: Eileen P. Scully, Monica Gandhi, Rowena Johnston, Rebecca Hoh, Ainsley Lockhart, Curtis Dobrowolski, Amélie Pagliuzza, Jeffrey M. Milush, Chris A. R. Baker, Valerie Girling, Arlvin Ellefson, Robert J. Gorelick, Jeffrey D. Lifson, Marcus Altfeld, Galit Alter, Marcelle I. Cedars, Ajantha Solomon, Sharon R. Lewin, Jonathan Karn, Nicolas Chomont, Peter Bacchetti, Steven G. Deeks - The Journal of Infectious Diseases 2018 cited by 96